Qube Research & Technologies (QRT)’s Elicio Therapeutics ELTX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ELTX Stock Details ELTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$133K	Sell	12,482 -7,734	-38%	-$74.7K	﹤0.01%	3023
2025 Q4	$161K	Buy	+20,216	New	+$183K	﹤0.01%	3098
2022 Q4	–	Sell	-1,433	Closed	-$13K	–	2592
2022 Q3	$13K	Sell	1,433 -129	-8%	-$1.35K	﹤0.01%	2338
2022 Q2	$18K	Buy	+1,562	New	+$24.9K	﹤0.01%	2275
2022 Q1	–	Sell	-1,141	Closed	-$33K	–	2587
2021 Q4	$33K	Buy	+1,141	New	+$57.7K	﹤0.01%	2316

Other funds holding ELTX

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ELTX Position: Q1 2026 in Review

Qube Research & Technologies (QRT) reduced its Elicio Therapeutics (ELTX) stake by 38% in Q1 2026, selling an estimated $74.7K and leaving 12,482 shares worth $133K. The position accounts for ﹤0.01% of the portfolio, ranked #3023.

Qube Research & Technologies (QRT) first reported a position in ELTX in Q4 2021 and has held it in 5 quarters since. The position peaked at $161K in Q4 2025. 47 funds tracked by Wall St. Rank hold ELTX as of Q1 2026.

Qube Research & Technologies (QRT) held 12,482 shares of Elicio Therapeutics worth $133K as of Q1 2026.
Qube Research & Technologies (QRT) sold 7,734 Elicio Therapeutics shares in Q1 2026, an estimated $74.7K.
Elicio Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #3023 holding.
Qube Research & Technologies (QRT) first reported a position in Elicio Therapeutics in Q4 2021 and has held it in 5 quarters since.
Qube Research & Technologies (QRT)'s Elicio Therapeutics position peaked at $161K in Q4 2025.
47 funds tracked by Wall St. Rank held Elicio Therapeutics as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.